眼科治療公司
DE ˙ DB ˙ US67576A1007
€7.15 ↑0.25 (3.62%)
2026-06-04
分享價格
SecurityDE:0OT / Ocular Therapeutix, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership55,777 shares
Latest Disclosed Value $ 472,431
Citigroup Inc ownership in 0OT / Ocular Therapeutix, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 55,777 shares of Ocular Therapeutix, Inc. (DE:0OT) valued at $370,582 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 601,917 shares of Ocular Therapeutix, Inc.. This represents a change in shares of -90.73% during the quarter. The current value of the position is $398,806 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (0OT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:0OT / Ocular Therapeutix, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 55,777 -546,140 -90.73 472 -93.54 0.0001
2026-02-13 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 601,917 -71,431 -10.61 7,307 -7.17 0.0032
2025-11-10 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 673,348 573,504 574.40 7,871 750.00 0.0035
2025-08-11 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 99,844 -32,143 -24.35 927 -4.24 0.0005
2025-05-12 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 131,987 -21,100 -13.78 967 -26.01 0.0005
2025-02-12 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 153,087 17,065 12.55 1,307 10.48 0.0008
2024-11-12 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 136,022 71,712 111.51 1,183 169.48 0.0007
2024-08-12 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 64,310 -53,995 -45.64 440 -59.20 0.0003
2024-05-10 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 118,305 99,128 516.91 1,077 1,165.88 0.0007
2024-02-09 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 19,177 -955 -4.74 86 34.92 0.0001
2023-12-06 2023-09-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 20,132 -16,013 -44.30 63 -66.13 0.0000
2023-11-09 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 20,132 -16,013 63 0.0000
2023-08-10 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 36,145 17,721 96.18 187 91.75 0.0001
2023-05-11 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 18,424 10,973 147.27 97 385.00 0.0001
2023-02-09 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 7,451 -583 -7.26 21 -39.39 0.0000
2022-11-10 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 8,034 -197,517 -96.09 33 -96.00 0.0000
2022-08-10 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 205,551 185,214 910.72 826 717.82 0.0006
2022-05-12 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 20,337 -12,759 -38.55 101 -56.28 0.0001
2022-02-10 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 33,096 -12,561 -27.51 231 -49.45 0.0001
2021-11-10 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 45,657 24,613 116.96 457 53.36 0.0003
2021-08-10 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 21,044 6,871 48.48 298 27.90 0.0002
2021-05-13 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 14,173 -7,310 -34.03 233 -47.64 0.0002
2021-02-11 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 21,483 -703 -3.17 445 163.31 0.0003
2020-11-12 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 22,186 11,319 104.16 169 85.71 0.0001
2020-08-12 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 10,867 -5,228 -32.48 91 13.75 0.0001
2020-05-12 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 16,095 4,719 41.48 80 77.78 0.0001
2020-02-12 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 11,376 -2,325 -16.97 45 7.14 0.0000
2019-11-08 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 13,701 3,876 39.45 42 -2.33 0.0000
2019-08-12 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 9,825 -1,095 -10.03 43 0.00 0.0000
2019-05-13 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 10,920 -8,446 -43.61 43 -44.87 0.0000
2019-02-12 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 19,366 17,438 904.46 78 500.00 0.0001
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,928 -11,972 -86.13 13 -86.17 0.0000
2018-08-10 2018-06-30 13F OCULAR THERAPEUTIX COM 67576A100 13,900 5,452 64.54 94 70.91 0.0001
2018-05-11 2018-03-31 13F OCULAR THERAPEUTIX COM 67576A100 8,448 -4,446 -34.48 55 -3.51 0.0000
2018-02-12 2017-12-31 13F OCULAR THERAPEUTIX COM 67576A100 12,894 6,425 99.32 57 42.50 0.0000
2017-11-13 2017-09-30 13F OCULAR THERAPEUTIX COM 67576A100 6,469 2,273 54.17 40 2.56 0.0000
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX COM 67576A100 4,196 -890 -17.50 39 -18.75 0.0000
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM 67576A100 5,086 5,086 48 0.0000
2016-11-10 2016-09-30 13F OCULAR THERAPEUTIX COM 67576A100 0 -1,620 -100.00 0 -100.00
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,620 -8,902 -84.60 8 -92.16 0.0000
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX COM 67576A100 10,522 5,833 124.40 102 131.82 0.0001
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX COM 67576A100 4,689 4,686 156,200.00 44 0.0000
2015-11-13 2015-09-30 13F OCULAR THERAPEUTIX COM 67576A100 3 -166 -98.22 0 -100.00
2015-08-13 2015-06-30 13F OCULAR THERAPEUTIX COM 67576A100 169 -146 -46.35 4 -69.23 0.0000
2015-05-14 2015-03-31 13F OCULAR THERAPEUTIX COM 67576A100 315 -29,358 -98.94 13 -98.14 0.0000
2015-02-17 2014-12-31 13F OCULAR THERAPEUTIX COM 67576A100 29,673 29,472 14,662.69 698 23,166.67 0.0006
2014-11-14 2014-09-30 13F OCULAR THERAPEUTIX COM 67576A100 201 201 3 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-11-08 2019-09-30 13F OCULAR THERAPEUTIX COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-12 2019-06-30 13F OCULAR THERAPEUTIX COM Call 17,400 14.47 77 28.33 n/a n/a n/a
2019-05-13 2019-03-31 13F OCULAR THERAPEUTIX COM Call 15,200 43.40 60 42.86 n/a n/a n/a
2019-02-12 2018-12-31 13F OCULAR THERAPEUTIX COM Call 10,600 -51.60 42 -72.19 n/a n/a n/a
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX COM Call 21,900 711.11 151 738.89 n/a n/a n/a
2018-08-10 2018-06-30 13F OCULAR THERAPEUTIX COM Call 2,700 -38.64 18 -37.93 n/a n/a n/a
2018-05-11 2018-03-31 13F OCULAR THERAPEUTIX COM Call 4,400 238.46 29 383.33 n/a n/a n/a
2018-02-12 2017-12-31 13F OCULAR THERAPEUTIX COM Call 1,300 -69.05 6 -76.92 n/a n/a n/a
2017-11-13 2017-09-30 13F OCULAR THERAPEUTIX COM Call 4,200 -74.70 26 -83.12 n/a n/a n/a
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX COM Call 16,600 12.16 154 12.41 n/a n/a n/a
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM Call 14,800 137 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-02-12 2019-12-31 13F OCULAR THERAPEUTIX COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-08 2019-09-30 13F OCULAR THERAPEUTIX COM Put 6,700 20 n/a n/a n/a
2019-08-12 2019-06-30 13F OCULAR THERAPEUTIX COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-13 2019-03-31 13F OCULAR THERAPEUTIX COM Put 7,700 -45.77 31 -45.61 n/a n/a n/a
2019-02-12 2018-12-31 13F OCULAR THERAPEUTIX COM Put 14,200 1,928.57 57 1,040.00 n/a n/a n/a
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX COM Put 700 -75.00 5 -73.68 n/a n/a n/a
2018-08-10 2018-06-30 13F OCULAR THERAPEUTIX COM Put 2,800 -61.11 19 -59.57 n/a n/a n/a
2018-05-11 2018-03-31 13F OCULAR THERAPEUTIX COM Put 7,200 0.00 47 46.88 n/a n/a n/a
2018-02-12 2017-12-31 13F OCULAR THERAPEUTIX COM Put 7,200 414.29 32 255.56 n/a n/a n/a
2017-11-13 2017-09-30 13F OCULAR THERAPEUTIX COM Put 1,400 -80.00 9 -86.15 n/a n/a n/a
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX COM Put 7,000 20.69 65 20.37 n/a n/a n/a
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM Put 5,800 54 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.